The global clinical trials market is estimated at over $80–90 billion in 2024 and is projected to surpass $120 billion by 2030, driven by rising R&D investments, the growth of biologics and precision medicine, and increasing trial complexity. The Asia-Pacific region is emerging as the fastest-growing market, as sponsors shift studies to geographies offering faster patient recruitment, cost efficiencies, and diverse populations. India is rapidly emerging as a premier hub for global clinical research, driven by its massive, diverse patient population and a cost advantage of 30–50% compared to Western markets.
This webinar will explore whether India can truly emerge as a global clinical trials hub by analysing current market dynamics, benchmarking against global trends, and identifying actionable strategies to enhance competitiveness and accelerate growth.
Key discussion points:
– India’s current position in the global clinical trials market
– Trial execution with data integrity and global compliance standards
– Strengthening infrastructure, investigator capability, and digital maturity
– Readiness for hybrid, tech-enabled, and remote trial models
– Enhancing patient protection, transparency, and public perception
– Government support and public-private collaboration
– Can India emerge as a preferred global clinical trial hub?
Join the live webinar and gain insights from our learning.